US Preparing for Zika

US Preparing for Zika

The United States of America is preparing for Zika to reach its shores. As it prepares, the CDC has an emergency response group working behind the scenes to anticipate and respond to this emerging health concern.  

#Zika

#Zika

For more information on what the CDC is doing to prepare for Zika see below... 

 

CDC prepares for Zika

Key Recent Data on Zika Cases in Brazil

Here is a recent update on cases being reported in Brazil on Zika.  The data was compiled by Brazil Ministry of Health and assembled by Ian MacKay, PhD.  

 

CNS and related effects of Zika

CNS and related effects of Zika

Confirmed Zika Diagnoses

Confirmed Zika Diagnoses

Top Medical Center Discusses Zika

Emory university, one of the first US hospitals to treat Ebola now prepares for the next health concern - Zika.  Here is a video of Grand Rounds at Emory university.  

image.jpg

 

 

Zika Prevention Starts with You

Want to learn more about how to prevent Zika?  This infographic from the US Centers for Disease Control may be helpful.  

 

Zika prevention starts with you

Zika prevention starts with you

Be proactive! 

Is there a path forward to treat Ebola?

4Africa.jpg

We really need to focus on how we address diseases that affect the entire global community. Ebola, as a disease, while still in Africa is certainly something that can affect other communities across the globe. Right now, many treatment strategies are still sitting on the shelf... We all understand the risks of developing new medicines, but when big pharma cannot find a business case to get behind something like this, we all have a problem. Let's start a new hashtag #globalconscience4Africa 

Nature put out an interesting article on technologies sitting on the shelf that could address infectious diseases in general...  When will enough people globally or at least in developed countries die from Ebola so that making a vaccine for it becomes profitable to big pharma given the significant investment required in research and development on the front end? The economic factors driving the lack of efforts have not been sufficiently discussed in mainstream media. The focus has been more on whether and how it might spread. Public pressure on big pharma is non-existent because we view this as an African disease and therefore not important. We accept that there is no cure but don't discuss the politics and economics of vaccine development. African lives at stake, the potential global spread of the disease, and the incredibly high mortality rate make finding a treatment/cure paramount.

A live updated feed on Ebola

Ebola virus outbreak: live - Telegraph





C. Diff vaccine from Sanofi continues to make progress

C. Diff vaccine from Sanofi continues to make progress

"In this trial, we saw a significant increase in antibody production against C. diff toxins, across all dosing schedules and volunteer ages," said Guy De Bruyn, MBBCh MPH, Director, Clinical Development, Sanofi Pasteur, who presented the data at ASM. "These results provide a strong foundation for our efforts to develop and offer a vaccine to prevent first occurrence CDI."